Emerging trends and utilization of patient-reported outcomes (PROs) in clinical trials of chimeric antigen receptor (CAR) T-cell therapies.

被引：0
|
作者：
Messina, Anthony John
Andrianov, Vasily
Mazzolenis, Daniel
Vidal-Fisher, Liat
机构：
[1] Syneos Hlth Oncol & Hematol, Port St Lucie, FL USA
[2] Syneos Hlth Oncol & Hematol, San Jose, CA USA
[3] Syneos Hlth Oncol & Hematol, Morrisville, NC USA
[4] Syneos Hlth Oncol & Hematol, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19142
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Longitudinal Patient-Reported Outcomes in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Johnson, Patrick Connor
    Dhawale, Tejaswini
    Lavoie, Mitchell W.
    Karpinski, Kyle
    Markovitz, Netana H.
    Hennessey, Kathleen
    Frigault, Matthew
    El-Jawahri, Areej
    BLOOD, 2022, 140 : 5232 - 5233
  • [2] Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
    Johnson, P. Connor
    Dhawale, Tejaswini
    Newcomb, Richard A.
    Amonoo, Hermioni L.
    Lavoie, Mitchell W.
    Vaughn, Dagny
    Karpinski, Kyle
    El-Jawahri, Areej
    BLOOD ADVANCES, 2023, 7 (14) : 3541 - 3550
  • [3] THE EMERGING ROLE OF PATIENT-REPORTED OUTCOMES (PROS) IN CLINICAL TRIALS IN INDIA
    Bn, V
    Naidu, M.
    Esam, H.
    Badgujar, L.
    Kinra, G.
    Dang, A.
    VALUE IN HEALTH, 2015, 18 (03) : A102 - A102
  • [4] Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps
    Afroz, Nuzhat
    Gutzwiller, Florian S.
    Mackay, Alex J.
    Naujoks, Christel
    Patalano, Francesco
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1789 - 1800
  • [5] GEOGRAPHIC TRENDS IN CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY ACCESS AND UTILIZATION
    McBride, K.
    Snyder, S.
    Serrano-Rubio, D.
    Gitlin, M.
    VALUE IN HEALTH, 2024, 27 (06) : S218 - S218
  • [6] Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
    Efficace, Fabio
    Cannella, Laura
    Sparano, Francesco
    Giesinger, Johannes M. M.
    Vignetti, Marco
    Baron, Frederic
    Bruera, Eduardo
    Luppi, Mario
    Platzbecker, Uwe
    HEMASPHERE, 2022, 6 (12): : E802
  • [7] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Ajeet Gajra
    Abigail Zalenski
    Aishwarya Sannareddy
    Yolaine Jeune-Smith
    Kandice Kapinos
    Ankit Kansagra
    Pharmaceutical Medicine, 2022, 36 : 163 - 171
  • [8] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Gajra, Ajeet
    Zalenski, Abigail
    Sannareddy, Aishwarya
    Jeune-Smith, Yolaine
    Kapinos, Kandice
    Kansagra, Ankit
    PHARMACEUTICAL MEDICINE, 2022, 36 (03) : 163 - 171
  • [9] Longitudinal Patient-Reported Outcomes (PROs) in a Prospective Registry of CAR T-Cell Therapy Recipients
    Major, Ajay
    Althaus, Thomas
    Brewer, Benjamin
    Schmiege, Sarah
    Kline, Justin
    Bishop, Michael R.
    Studts, Jamie L.
    Cook, Paul
    Riedell, Peter A.
    BLOOD, 2023, 142
  • [10] Infectious complications of chimeric antigen receptor (CAR) T-cell therapies
    Gea-Banacloche, Juan C.
    SEMINARS IN HEMATOLOGY, 2023, 60 (01) : 52 - 58
12345